ATE268170T1 - Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz - Google Patents

Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz

Info

Publication number
ATE268170T1
ATE268170T1 AT99933301T AT99933301T ATE268170T1 AT E268170 T1 ATE268170 T1 AT E268170T1 AT 99933301 T AT99933301 T AT 99933301T AT 99933301 T AT99933301 T AT 99933301T AT E268170 T1 ATE268170 T1 AT E268170T1
Authority
AT
Austria
Prior art keywords
insulin resistance
salts
summeric
acid
treat insulin
Prior art date
Application number
AT99933301T
Other languages
English (en)
Inventor
Igor Anatolievich Pomytkin
R-On Noginsky
Olga Evgenievna Kolesova
Tatiyana Jurievna Ukhanova
Original Assignee
Verteletsky Pavel Vasilievich
Igor Anatolievich Pomytkin
Olga Evgenievna Kolesova
Tatiyana Jurievna Ukhanova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verteletsky Pavel Vasilievich, Igor Anatolievich Pomytkin, Olga Evgenievna Kolesova, Tatiyana Jurievna Ukhanova filed Critical Verteletsky Pavel Vasilievich
Application granted granted Critical
Publication of ATE268170T1 publication Critical patent/ATE268170T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
AT99933301T 1999-03-01 1999-03-01 Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz ATE268170T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1999/000055 WO2000051594A1 (en) 1999-03-01 1999-03-01 Use of succinic acid or salts thereof and method of treating insulin resistance

Publications (1)

Publication Number Publication Date
ATE268170T1 true ATE268170T1 (de) 2004-06-15

Family

ID=20130328

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933301T ATE268170T1 (de) 1999-03-01 1999-03-01 Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz

Country Status (10)

Country Link
US (1) US6521665B1 (de)
EP (1) EP1156795B1 (de)
AT (1) ATE268170T1 (de)
AU (1) AU4937499A (de)
CA (1) CA2366073A1 (de)
DE (1) DE69917809T2 (de)
DK (1) DK1156795T3 (de)
ES (1) ES2222717T3 (de)
PT (1) PT1156795E (de)
WO (1) WO2000051594A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0017206A (pt) * 2000-04-10 2003-01-14 Igor Anatolievich Pomytkin Composições sinergìsticas contendo base colina e ácido succìnico para resistência a insulina e diabetes
EA016274B1 (ru) * 2007-08-02 2012-03-30 Игорь Анатольевич Помыткин Применение янтарной кислоты для профилактики и лечения нейродегенеративных заболеваний
US20120107850A1 (en) * 2009-07-15 2012-05-03 Panasonic Corporation Analysis reagent and analysis device having the analysis reagent carried therein
JP5460183B2 (ja) * 2009-08-28 2014-04-02 パナソニック株式会社 分析用試薬および分析用デバイス
WO2019244133A1 (en) * 2018-06-22 2019-12-26 Enzene Biosciences Limited Succinic acid and derivatives for the treatment of haemotological disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61171417A (ja) 1985-01-23 1986-08-02 Wakunaga Seiyaku Kk 抗糖尿病剤
JP3581157B2 (ja) 1992-08-19 2004-10-27 株式会社ミツカングループ本社 低耐糖能者用食品

Also Published As

Publication number Publication date
EP1156795A1 (de) 2001-11-28
DE69917809D1 (de) 2004-07-08
CA2366073A1 (en) 2000-09-08
PT1156795E (pt) 2004-09-30
ES2222717T3 (es) 2005-02-01
WO2000051594A1 (en) 2000-09-08
AU4937499A (en) 2000-09-21
US6521665B1 (en) 2003-02-18
EP1156795B1 (de) 2004-06-02
DE69917809T2 (de) 2004-11-04
DK1156795T3 (da) 2004-11-01

Similar Documents

Publication Publication Date Title
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
UA85055C2 (ru) Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний
DE60039783D1 (de) Lfa-1 antagonisten und tnf-alpha antagonisten zur
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
DE60036456D1 (de) Antimikrobiell wirksames oder endotoxin neutralisierendes polypeptid
PT950057E (pt) Enantiomeros de 3-piridilo e sua utilizacao como analgesicos
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
EA199800866A1 (ru) Способ снятия боли
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
DE69733557D1 (de) Endothelin-antagonisten zur behandlung von herzversagen
DE60325965D1 (de) Für die behandlung bzw. prevention von schmerzen geeignete triazaspiroverbindungen
ATE239467T1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
DE69623316T2 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
ATE537838T1 (de) Kombinationstherapie mit kloretazin(tm)
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE602004016547D1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1156795

Country of ref document: EP

REN Ceased due to non-payment of the annual fee